AdverseEvent.ai
This page presents data from the FDA Adverse Event Reporting System (FAERS) and the FDA-approved drug label. A report submitted to FAERS does not prove a drug caused the reported event. Always consult a healthcare provider about medications.

Rompe Pechito Dm For Kids (guaifenesin)

expectorant
Last updated: June 21, 2026
Preview tracking

Rompe Pechito Dm For Kids is the brand name for guaifenesin, a expectorant. According to the FDA-approved label, temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes. FAERS contains 29,813 submissions naming this drug from 1998 through 2026; the top three reactions cited are drug ineffective, dyspnoea, and fatigue.

Most-Reported Reactions

Counts of the reactions most often cited in FAERS submissions that named Rompe Pechito Dm For Kids. Inclusion here does not establish causation - submitters describe what was observed, not what was confirmed. One submission can list several reactions, so the totals exceed the report count.

DRUG INEFFECTIVE 2,469 (8.3%) DYSPNOEA 2,217 (7.4%) FATIGUE 1,813 (6.1%) NAUSEA 1,784 (6.0%) DIARRHOEA 1,685 (5.7%) PNEUMONIA 1,678 (5.6%) COUGH 1,596 (5.4%) HEADACHE 1,536 (5.2%) DIZZINESS 1,421 (4.8%) PAIN 1,276 (4.3%) OFF LABEL USE 1,000 (3.4%) VOMITING 961 (3.2%) ASTHENIA 939 (3.1%) DEATH 937 (3.1%) FALL 909 (3.0%)

Patient Demographics

Patient sex and age across the FAERS submissions that named Rompe Pechito Dm For Kids. Percentages here are computed only from submissions where these fields were filled in - many leave them blank.

By Sex

Female Male Unknown

By Age Group

0-17 18-44 45-64 65+

Severity Outcomes

Severity flags recorded across the 29,813 FAERS submissions that named Rompe Pechito Dm For Kids. Each bar shows the count of those reports carrying that flag. A single case can carry more than one (a hospitalization that became life-threatening, for example), so these bars are independent rates - they don't sum to 100%. Inclusion of a case under any flag does not establish that the drug caused the outcome.

DEATH 2,186 (7.3%) HOSPITALIZATION 7,711 (25.9%) LIFE-THREATENING 652 (2.2%) DISABLING 502 (1.7%)

Submissions Per Quarter

Quarterly count of FAERS submissions that named Rompe Pechito Dm For Kids. Ups and downs on this chart can track prescribing volume, news cycles, or shifts in how reports get filed, rather than the drug becoming safer or more dangerous.

1998 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

From the FDA-Approved Label

Excerpts from the official FDA-approved prescribing information for Rompe Pechito Dm For Kids. This is the authoritative source on indications, warnings, and known adverse reactions.

Indications

s: temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes.

Warnings

Do not use in child who is taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional condition, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your child’s prescription drug contains an MAOI, ask a doctor or pharmacist before giving this product.

FDA label effective date: 2025-10-14

Disclaimer

AdverseEvent.ai is not affiliated with the FDA. Adverse-event counts come from the FDA Adverse Event Reporting System (FAERS). Drug labels come from the FDA drug label dataset. A report submitted to FAERS does not prove a drug caused the reported event — always consult a healthcare provider about medications. This site is for informational purposes only and is not medical advice.